Genmab A/S (GMAB)

NMS – Real Time Price. Currency in USD

31.36

+0.51 (1.65%)

Market open: Aug 12, 2026, 3:47 PM EDT

31.24

+0.39 (1.28%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

3.73B

3.12B

2.39B

2.05B

Cost of goods sold

-310M

-203M

-80M

Gross Profit

3.42B

2.92B

2.31B

Operating expenses (excl. COGS)

-2.17B

-1.90B

-1.54B

-1.12B

Operating Income

1.25B

1.02B

772M

891M

Non-operating income, total

-46M

313M

46M

90M

Pretax income

1.21B

1.33B

818M

981M

Equity in earnings

Taxes

-242M

-191M

-186M

-211M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

966M

1.14B

631M

770M

Discontinued operations

Net income

966M

1.14B

631M

770M

Dilution adjustment

Preferred dividends

Genmab A/S (GMAB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Genmab A/S (GMAB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Genmab A/S (GMAB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Genmab A/S (GMAB)

Income Statement (Annual)

Income Statement (Annual)